.webp&w=3840&q=75)
Cell, Gene and Novel Therapies
The Master of Science (MSc) in Cell, Gene, and Novel Therapies at University College London (UCL) is a one-year, full-time, on-campus program designed for students interested in advanced research and applications in genetic therapies. The program focuses on the latest innovations in gene editing, cell therapies, and novel therapeutic approaches, preparing students to contribute to the rapidly evolving field of molecular medicine.
UCL’s program offers a unique blend of theoretical and practical learning, with a focus on translating scientific discoveries into clinical applications. Students will gain hands-on experience in cutting-edge techniques such as CRISPR, stem cell research, and gene therapy, equipping them to drive advancements in medical treatments for a variety of diseases.
Key information
Key Facts
- Program Title: Master of Science in Cell, Gene, and Novel Therapies
- Degree Type: Master's Degree
- Duration: 1 year
- Mode of Study: Full-time, On Campus
- Application Deadline: 29th August 2026
- Location: University College London (UCL), United Kingdom
- Field of Study: Genetics
- Language of Instruction: English
Program Structure
The MSc in Cell, Gene, and Novel Therapies offers a multidisciplinary curriculum combining molecular genetics, biotechnology, and clinical applications. Students will explore gene therapies, regenerative medicine, and the latest developments in personalized medicine. The program includes lectures, laboratory-based practicals, seminars, and a research dissertation where students will conduct original research in the field of gene and cell therapy.
Career Opportunities
Graduates of the MSc in Cell, Gene, and Novel Therapies from UCL are well-prepared for careers in biotechnology, pharmaceutical industries, and academic research. Potential roles include geneticist, molecular biologist, clinical researcher, and biotechnology consultant. The program’s focus on cutting-edge therapeutic approaches ensures that graduates are highly competitive in industries dedicated to innovative medical treatments and disease prevention.
Why Choose This Program
The MSc in Cell, Gene, and Novel Therapies at UCL stands out for its focus on the latest advances in genetic and cell-based therapies. UCL’s strong reputation in genetics, alongside its state-of-the-art research facilities, provides students with an ideal environment to develop specialized skills in the application of molecular therapies. The program prepares graduates to lead in the development of next-generation medical treatments and personalized medicine.
Contact Information
For further information, please contact the admissions office at:
Phone: +44 (0)20 7679 2000
Email: study@ucl.ac.uk
Address: University College London, Gower Street, London WC1E 6BT, United Kingdom
